Clinical trial
Immediate Efficacy Assessment of SCENAR's Session on a Common Spinal Pain Syndrome
NCT03755817 is registered in ClinicalTrials.gov with Hopital Foch as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Immediate Efficacy Assessment of SCENAR's Session on a Common Spinal Pain Syndrome
- Lead sponsor
- Hopital Foch
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 14, 2018
- Completion date
- November 21, 2020
- Enrollment
- 60 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
pain syndrome